The Mass General Cancer Center ASH Review and Practice-Changing Updates will be an interactive, virtual educational program highlighting state-of-the-art care for patients with hematologic diseases. Talks will focus on the latest science presented during the 2021 ASH Annual Meeting. Each major disease center will have a one-hour time slot to present practice-changing studies in their field: myeloma, benign hematology, bone marrow transplant, leukemia, and lymphoma. There will be designated time in each section for a moderated Q&A, encouraging interaction between audience and faculty.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants will be able to:

• Manage complex patients with lymphoma/myeloma through knowledge of new treatment options
• Evaluate new drugs and combination therapy for leukemia and bone marrow transplant.
• Discuss new advancements in the identification and treatment of benign hematology.

TARGETED AUDIENCE

This course is targeted to Specialty Physicians, Physician Assistants and Nurse Practitioners. This course may also be of interest to physicians who practice in Oncology and Hematology.

ACCREDITATION

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Harvard Medical School designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.